
Intech
A French maker of orthopedic surgical instruments. Since 2014 we have built its name with OEMs in the US, through six acquisitions folded into one brand. Intech is now part of Exalta.
The Exalta announcement ↗Win the US market with a team that speaks MedTech.
Strategic advisors and a full marketing team, in one. We take you from your first US plan to meetings with American buyers.

Some of the international companies we’ve helped








Surgeons and hospitals buy from companies they already trust.
What works in Germany or France often falls flat in the US.
Six hours of time difference, and nobody on the ground to follow up.
Meanwhile, your board approved the US budget and is waiting for results.
Realists makes surgical training simulators in Leipzig. We started taking it to the US market in 2026, and the work is ongoing.

A French maker of orthopedic surgical instruments. Since 2014 we have built its name with OEMs in the US, through six acquisitions folded into one brand. Intech is now part of Exalta.
The Exalta announcement ↗
An Australian MedTech company bringing Nurochek, an FDA cleared portable concussion assessment system, to the US. We act as its US marketing department: US buyer profiles, the American story and the launch plan.
US launch in progressVisit headsafe.com ↗Headsafe’s US press release ↗
From 2015 to 2018 we were Mazor’s marketing team as it grew in the US with robotic guided spine surgery. In 2018, Medtronic acquired Mazor Robotics.
Medtronic’s announcement ↗
A German surgical robotics company bringing noac, a robotic surgeon assist for open surgery, to the US. Its US launch started with spine and built toward NASS 2026.
US launch in progressRead the press release ↗Read the Digest interview ↗Every quarter, we review the plan and the results with your leadership.
How American buyers see you today: your website, your claims and your US materials.
Your goals, your timeline and your US budget, until we clearly understand them.
Your three stage US launch plan, built with MT-7, our Framework for Growth. You approve it.
Our team runs it as your US marketing department, with a shared Gantt chart and a weekly and a monthly action report.
Each stage ends with something you can use. You can start with stage 1 on its own and keep the plan either way. Below are the first six months, taken from the plans we run for clients today.
This is our master framework, and your plan is made to measure. We cut every Gantt for one company: your products, your buyers, your shows, your budget and your dates. No two of our plans look alike.
How to read it. Each row is a workstream, each bar is when we work on it. The numbered markers are the moments you approve or go live.
What it means for you. You see the US story approved in about five weeks and meetings booked before your launch show. This framework is drawn from the real plans we run for our US launch clients.
MT-7, our Framework for Growth, builds your plan in seven steps, always in the same order:
We act as your US marketing department until you build your own, and we stay as long as you need us. We also advise your leadership on the big US decisions. We are based in Orlando, Florida, and our network gets you introductions you would struggle to get on your own.

Founder and President
European and American. Advises your leadership on every key US decision: positioning, partners, distributors and investors. In English, French or Spanish.
LinkedIn →




We pitch your US launch story to the editors, so you do not arrive cold.
Within 5 business days: where you stand next to two or three US competitors, the three problems that cost you most, and what to fix first. Then a 30 minute call, in English, French or Spanish.
Free for medical device companies planning their US launch.
We founded The MedTech Digest to cover the people building MedTech. When you have news worth telling, we pitch it to the editors. They decide what runs.
Free monthly newsletter. Interviews, industry news and MedTech marketing.
Featured interviewDr. Luis Bernal, CEO of REALISTSHow a German surgical training company is bringing its spine simulators to the US. Read the interview ↗
Subscribe
Experts in Motion interviewFrom Leipzig to the OR: How REALISTS Is Bringing Next Generation Spine Simulation to the United StatesMay 14, 2026







No More Guesswork: Headsafe
Hospitals Are Losing Surgeons.It is the plan that takes a device, or a new manufacturing capability, from approval to steady US sales. It defines who buys, what they need to hear, the proof they need, how you reach them and in what order. At MedTech Momentum it starts as a written US marketing plan: target segments, messaging for each, competitors, KPIs and a timeline, built backward from your US sales goal.
Almost everything around the device. A hospital committee decides, not only the surgeon. The message has to be clear and about outcomes. Claims must match your FDA clearance. Sales run through independent reps, distributors and group purchasing. And US buyers want US proof.
Stage 1 takes about five weeks. The launch foundation runs through month four, and demand generation starts in the second month and keeps going. Building steady US sales takes longer, so every stage has milestones you can track.
Yes. We map the distributors and independent reps who cover your specialty and regions, give them the materials they need, and make introductions through our network. You choose and sign your partners.
No. We work from your FDA cleared claims, alongside your regulatory and reimbursement advisors, and every message is reviewed before it goes public. If you do not have those advisors yet, we can introduce you.
Yes. We work in English, French and Spanish, with your headquarters and your US lead together, and we plan calls in the hours our time zones share.
Yes, with a different plan. They sell to OEM engineering, quality and sourcing teams, so the message, the proof and the materials are different. See how we help manufacturers.
Guillaume ViallaneixFounder and PresidentIn 30 minutes, we check six things: clearance, evidence, your US owner, target customers, budget and sales support. Then we tell you where your US launch should start.
Not ready for a call? Get a free audit of your digital footprint
Prefer email? [email protected] · +1 (321) 946 1303